Results
Emcure FY26 Revenue Crosses ₹9,204 Cr, PAT Up 33%
Emcure Pharmaceuticals reported audited standalone and consolidated financial results for Q4 and FY26 ended March 31, 2026, approved by the Board on May 5, 2026.
Consolidated revenue reached ₹9,204.40
